Charles Russell Speechlys advises Elysian Capital on the acquisition of Key Travel
Charles Russell Speechlys has advised Elysian Capital on the acquisition of Key Travel, the leading travel management company.
Currently operating in 54 countries worldwide, with over 1,900 clients, Key Travel provides travel and risk management services to clients in the not for profit humanitarian, faith and academic sectors. Clients include WWF and ActionAid, along with 40% of the top 24 research-based universities in the UK.
Since 2013, Key Travel has accelerated its US expansion through the opening of its Philadelphia office in 2013 and the 2016 acquisition of the Boston based OT&T. The Group is looking to further ramp up global growth and expand across new geographies over the next few years.
Edward Brett of Elysian Capital commented “Charles Russell Speechlys did an excellent job of navigating through the complexity of acquiring a US and U.K. regulated business in an accelerated five week time frame. They delivered a real team work driven performance through a challenging but enjoyable transaction.”
Partner, Malcolm MacDougall, commented “We are delighted to have advised long-standing client Elysian Capital on the acquisition of Key Travel. It was a pleasure working with the Elysian Capital team once again and we look forward to seeing the business grow from strength to strength.”
The Charles Russell Speechlys core team included Corporate Partner and Head of Private Equity Malcolm MacDougall, corporate associates Chris Manning, Nicola Baird, Rajiv Kakkad and Dafni Loizou, as well as support from specialist teams, including: Banking Partner, Daniel Sullivan and Banking associates Leah Rushton, Celine Jones, Malacia Madden and Roya Zohrabi, Commercial Senior Associate, Caroline Young, Tax specialists, Helen Coward and Andrew Priestly and Employment associates Emilie Bennetts and Syma Spanjers.
News & Insights
Chares Russell Speechlys advises Turner Parkinson on its sale to Knights
Charles Russell Speechlys has advised independent business law firm Turner Parkinson LLP on its acquisition by Knights 1759.
Charles Russell Speechlys advises Kreos and SVB on £20m growth capital investment to Mereo BioPharma
We advised Kreos Capital and Silicon Valley Bank on the refinancing of £20 million growth capital investment to Mereo BioPharma Group